Duloxetine HCL DR 20 MG cap 1000S
Ended Awarded Last action
- Contract number
- SPE2DR26FS8NR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,544
Award facts
- Contract value 100% obligated
- $2,543.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,543.89 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 20 mg capsules (1,000 units). The contract employs firm fixed price pricing with no set-aside designation and has an ultimate completion date of December 12, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and healthcare procurement through its DLA contracts. The company's extensive federal portfolio encompasses a broad range of pharmaceuticals and medical supplies across multiple therapeutic domains, including neurological treatments, pain management medications, and specialty drugs. This particular delivery order for Duloxetine HCL, a common antidepressant and pain management medication, supports the Defense Health Agency's pharmaceutical supply requirements. The Pharmaceutical Prime Vendor Global Program framework under which this contract operates provides flexible, streamlined procurement of essential medications to military healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FS8NR?
SPE2DR26FS8NR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FS8NR worth?
The government has obligated $2,544 on SPE2DR26FS8NR.
Is contract SPE2DR26FS8NR an order under another contract?
Yes. SPE2DR26FS8NR is a delivery order under SPE2DR25D3021, an indefinite delivery contract.
Was contract SPE2DR26FS8NR competed?
The extent of competition for SPE2DR26FS8NR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award